Cellect Biotechnology Ltd. is a company focused on enabling regenerative medicine through the mass enrichment of stem cells. Founded in 2011, its goal is to make quality stem cells easily available in mass for all medicinal purposes. Stem cells are recognized as the foundation of 21st century medicine, and without the necessary technologies to enable their mass enrichment, stem cell-based treatments will remain within the confines of laboratories and clinical trials. Cellect Biotechnology Ltd. is working to make regenerative medicine publicly available to all people through their groundbreaking technology.